These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3180479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ, Maxwell RJ.
    Clin Chim Acta; 1982 Aug 18; 123(3):311-9. PubMed ID: 6811164
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Further evidence of a primary mucosal defect in coeliac disease.
    Cornell HJ, Rolles CJ.
    Gut; 1978 Apr 18; 19(4):253-9. PubMed ID: 648934
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mucosal digestion studies of whole gliadin fractions in coeliac disease.
    Cornell HJ.
    Ann Clin Biochem; 1990 Jan 18; 27 ( Pt 1)():44-9. PubMed ID: 2310157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Separation of pure toxic peptides from a beta-gliadin subfraction using high-performance liquid chromatography.
    Jos J, de Tand MF, Arnaud-Battandier F, Boissel JP, Popineau Y, Wajcman H.
    Clin Chim Acta; 1983 Oct 31; 134(1-2):189-98. PubMed ID: 6652909
    [Abstract] [Full Text] [Related]

  • 10. Isolation of coeliac active peptide fractions from gliadin.
    Wieser H, Belitz HD, Ashkenazi A, Idar D.
    Z Lebensm Unters Forsch; 1983 Oct 31; 176(2):85-94. PubMed ID: 6405556
    [Abstract] [Full Text] [Related]

  • 11. Digestion of gliadin peptides by intestinal mucosa from control or coeliac children.
    Carchon H, Serrus M, Eggermont E.
    Digestion; 1979 Oct 31; 19(1):1-5. PubMed ID: 378739
    [Abstract] [Full Text] [Related]

  • 12. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M, Stammati A, Luchetti R, Silano M, Gasbarrini G, Silano V.
    Toxicology; 1998 May 15; 127(1-3):97-106. PubMed ID: 9699797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The activity of wheat gliadin peptides in in vitro assays for coeliac disease.
    Cornell HJ, Mothes T.
    Biochim Biophys Acta; 1993 Apr 30; 1181(2):169-73. PubMed ID: 8481406
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.